glp-1 drugs and anxiety Anxiety: Clinical Insights (public) Weight-loss drugs could alleviate anxiety

In preclinical in vitro work, GIPR signalling has been associated with lipid partitioning in adipocyte models and potentiation of insulin secretion under hyperglycaemic conditions

The rate at which the medical community is giving out these drugs tells me that were hitting a lot of people with a predisposition for eating disorders. Turner hopes that clinicians prescribing these drugs will take screening for eating disorders seriously and recognize that people can have eating disorders at every size

Prebiotic fiber: the microbiome feeders Prebiotic fibers are a specific subset of fibers, usually soluble and fermentable, that selectively feed beneficial gut bacteria

Nat Med 29(9):23582365 Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ, Hovingh GK, Kitzman DW, Mller DV, Verma S et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

406 FGF21 is recognized as a stress response factor that addresses mitochondrial dysfunction in cells

Clinical studies and our extensive patient experience at Internal Medicine and Family Practice show that the vast majority of patients experience a substantial decrease in hunger and achieve meaningful weight loss